Christopher J. Corrigan

Active 1988–2025

94
Papers
20,576
Citations
76
h-index
91
i10-index

Citations

Citations per year for Christopher J. Corrigan1990: 2 citations1991: 19 citations1992: 50 citations1993: 96 citations1994: 100 citations1995: 125 citations1996: 120 citations1997: 152 citations1998: 181 citations1999: 266 citations2000: 175 citations2001: 183 citations2002: 120 citations2003: 147 citations2004: 111 citations2005: 108 citations2006: 121 citations2007: 114 citations2008: 134 citations2009: 147 citations2010: 199 citations2011: 191 citations2012: 203 citations2013: 172 citations2014: 165 citations2015: 161 citations2016: 153 citations2017: 170 citations2018: 129 citations2019: 467 citations2020: 478 citations2021: 411 citations2022: 372 citations2023: 263 citations2024: 301 citations2025: 170 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,977 citing papers, 23.6% of this breakdownUnited Kingdom: 1,106 citing papers, 13.2% of this breakdownChina: 422 citing papers, 5% of this breakdownItaly: 395 citing papers, 4.7% of this breakdownCanada: 382 citing papers, 4.6% of this breakdownJapan: 353 citing papers, 4.2% of this breakdownGermany: 344 citing papers, 4.1% of this breakdownFrance: 297 citing papers, 3.5% of this breakdownAustralia: 284 citing papers, 3.4% of this breakdownNetherlands: 268 citing papers, 3.2% of this breakdownBelgium: 210 citing papers, 2.5% of this breakdownSpain: 203 citing papers, 2.4% of this breakdown
0%23.6%Other 25.6%

Fields

  • Medicine69.5%
  • Immunology and Microbiology18.7%
  • Biochemistry, Genetics and Molecular Biology7.2%
  • Environmental Science1.3%
  • Neuroscience1.1%
  • Nursing0.6%
  • Other1.6%

Topics

  • Asthma and respiratory diseases20.5%
  • IL-33, ST2, and ILC Pathways8.4%
  • Allergic Rhinitis and Sensitization6.1%
  • Immune Cell Function and Interaction3.8%
  • Respiratory and Cough-Related Research3.6%
  • Eosinophilic Esophagitis3.5%
  • Other54.1%

Coauthors

All papers

Open in search
  1. Defining a Severe Asthma Super-Responder: Findings from a Delphi Process

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Εleftherios Ζervas, Enrico Heffler, Flavia Hoyte, Francesca Puggioni, George Christoff, Giorgio Walter Canonica, Giovanna Elisiana Carpagnano, Giuseppe Guida, Gregory Katsoulotos, Guy Brusselle, Hitashi Rupani, Hubertus Jersmann, I. Clifton, Jaideep Dhariwal, James Fingleton, Jane Duke, Janet Rimmer, John Aubrey Douglass, João Fonseca, Job F. M. van Boven, John Corless, John Harrington, Jorge Máspero, José Luís San Miguel, Kanok Pipatvech, Karrinda Kenny, Kenneth R. Chapman, Κonstantinos Κostikas, Lauri Lehtimäki, Li Ping Chung, Liam G. Heaney, Liang‐Wen Hang, Louis‐Philippe Boulet, Luis Pérez de Llano, L Ricciardi, Majdy Idrees, Manlio Milanese, Maria Elisabetta Conte, Maria Teresa Costantino, Mariko Koh Siyue, Mark Fitzgerald, Mark Hew, Matthew Peters, Ming‐Ju Tsai, Mitesh Patel, Mohammad Hashim Khan, Mohsen Sadatsafavi, Mona Al‐Ahmad, Mona‐Rita Yacoub, Mónica De Gennaro, Naghmeh Radhakrishna, Nicola A. Hanania, Nikolaos G. Papadopoulos, Njira Lugogo, Norma Linaker, Nunzio Crimi, Paddy Dennison, Parameswaran Nair, Patrick Mitchell, Paul M. O’Byrne, Paul Pfeffer, Paula Kauppi, Pauline Hughes, Peter G. Middleton, Peter Wark, Philip G. Bardin, Pin‐Kuei Fu, Praveen Akuthota, Rekha Chaudhuri, R. Diaz Campos and 18 more - The Journal of Allergy and Clinical Immunology In Practice 2021 cited by 145

  2. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study

    Authors: , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2015 cited by 588

  3. Expression and Cellular Provenance of Thymic Stromal Lymphopoietin and Chemokines in Patients with Severe Asthma and Chronic Obstructive Pulmonary Disease

    Authors: , , , , , , , , , , , , - The Journal of Immunology 2008 cited by 401

  4. Elevated Expression of IL-33 and TSLP in the Airways of Human Asthmatics In Vivo: A Potential Biomarker of Severe Refractory Disease

    Authors: , , , , , , , - The Journal of Immunology 2018 cited by 190

  5. IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway Inflammation

    Authors: , , , , , , , , , , , , , , - The Journal of Immunology 2009 cited by 708

  6. Thymic Stromal Lymphopoietin Expression Is Increased in Asthmatic Airways and Correlates with Expression of Th2-Attracting Chemokines and Disease Severity

    Authors: , , , , , , , , , , - The Journal of Immunology 2005 cited by 860

  7. IL-33 Initiates Vascular Remodelling in Hypoxic Pulmonary Hypertension by up-Regulating HIF-1α and VEGF Expression in Vascular Endothelial Cells

    Authors: , , , , , , , , , - EBioMedicine 2018 cited by 221

  8. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC–activated Th2 memory cells

    Authors: , , , , , , , , , , , , , - The Journal of Experimental Medicine 2007 cited by 663

  9. Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic Asthma

    Authors: , , , , , , , , - New England Journal of Medicine 1992 cited by 2,766

  10. Bronchial Allergen Challenge of Patients with Atopic Asthma Triggers an Alarmin (IL-33, TSLP, and IL-25) Response in the Airways Epithelium and Submucosa

    Authors: , , , , , , , - The Journal of Immunology 2018 cited by 140

  11. Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Debra H. Josephs, Sophia N. Karagiannis - Nature Communications 2023 cited by 36

  12. Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard W. Costello, Christopher J. Corrigan, Sarah Davies, Gareth Davies, Kian Fan Chung, Gabrielle Gainsborough, Traceyanne Grandison, Beverley Hargadon, A. Van Horn, Val Hudson, David J. Jackson, Sebastian L. Johnston, Geraldine Jones, Paula McCourt, María del Rocío Guillen Núñez, Dominick Shaw, Katherine Smith, Joel Solis, Roisin Stone, Freda Yang - The Lancet Respiratory Medicine 2020 cited by 137

  13. Vitamin D 3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2014 cited by 232

  14. Inhaler devices – From theory to practice

    Authors: , , , - Respiratory Medicine 2013 cited by 151

  15. Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis

    Authors: , , , , , , , , - Respiratory Research 2020 cited by 96

  16. Combined blockade of IL‐25, IL‐33 and TSLP mediates amplified inhibition of airway inflammation and remodelling in a murine model of asthma

    Authors: , , , , , , , , , , , - Respirology 2019 cited by 52

  17. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD

    Authors: , , , , , , , , , , , , - Respiratory Medicine 2007 cited by 610

  18. Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma

    Authors: , , , , , , - Journal of Allergy and Clinical Immunology 2007 cited by 260

  19. Retail sales of inhalation devices in European countries: So much for a global policy

    Authors: , , , , , , , , - Respiratory Medicine 2011 cited by 173

  20. AllergoOncology – the impact of allergy in oncology: EAACI position paper

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Luca Vangelista, Sophia N. Karagiannis - Allergy 2016 cited by 94

  21. Distinct endotypes of steroid-resistant asthma characterized by IL-17Ahigh and IFN-γhigh immunophenotypes: Potential benefits of calcitriol

    Authors: , , , , , , , , - Journal of Allergy and Clinical Immunology 2015 cited by 181

  22. Calcium-sensing receptor antagonists abrogate airway hyperresponsiveness and inflammation in allergic asthma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2015 cited by 177

  23. Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells

    Authors: , , , , , - Journal of Allergy and Clinical Immunology 2006 cited by 123

  24. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3supplementation in adults with asthma (ViDiAs)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Thorax 2015 cited by 122